Tue, Jan 27, 2015, 10:07 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • system_architect_enterprise system_architect_enterprise Oct 16, 2012 9:35 PM Flag

    Approval could shoot to $45-$60/share

    With the negative view on ISIS today, a favorable vote by the panel tomorrow could rocket the stock towards the $45-$60 range based on $300,000 per year per patient, a patient population of 6,000 and a total market therefore of $1.8B/year.

    With 25M shares outstanding, that $1.8B equates to $72/share. Now not all patients will go on the medication, but these are the numbers we are dealing with. Therefore a $45-$60/share target price is very reasonable and a share price below that makes a buyout compelling.

    It has to get the FDA panel vote first, so we have to wait and see what happens tomorrow. While it looks favorable, it isn't done yet. So one step at a time.

24.64-0.30(-1.20%)Jan 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Apple Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Yahoo! Inc.
NASDAQTue, Jan 27, 2015 4:00 PM EST
Horizon Pharma plc
NASDAQTue, Jan 27, 2015 4:00 PM EST